Further progress in cytosolic cellular delivery of quantum dots

Kelly Boeneman Gemmill; James B. Delehanty; Michael H. Stewart; Kimihiro Susumu; Juan B. Blanco-Canosa; Philip E. Dawson; Alan Huston; Igor Medintz

doi:10.1117/12.906801

2 February 2012 Further progress in cytosolic cellular delivery of quantum dots

Kelly Boeneman Gemmill; James B. Delehanty; Michael H. Stewart; Kimihiro Susumu; Juan B. Blanco-Canosa; Philip E. Dawson; Alan Huston; Igor Medintz

Author Affiliations +

Proceedings Volume 8232, Colloidal Nanocrystals for Biomedical Applications VII; 82320B (2012) https://doi.org/10.1117/12.906801
Event: SPIE BiOS, 2012, San Francisco, California, United States

Abstract

Currently there is considerable interest in using bioconjugated nanoparticles for in vivo imaging, biosensing and theranostics. Luminescent CdSe/ZnS core shell semiconductor quantum dots (QDs) have unique optical properties and bioconjugation capabilities that make them ideal prototypes for these purposes. We have previously described the metal-affinity association between the imidazole groups of terminal hexahistidine residues of peptides and proteins and the ZnS shell of quantum dots as a useful bioconjugation technique. We have also demonstrated that QDs labeled with an oligohistidine-tagged cell penetrating peptide (CPP) derived from the HIV TAT-protein could undergo specific endocytosis-mediated cellular uptake in both HEK293T/17 and COS-1 cells. However, the QDs were predominantly sequestered in the endosomes. This remains a significant hindrance to future potential cellular imaging applications which require the QDs to access other subcellular organelles. Here we describe the testing of several cytosolic QD delivery modalities including microinjection, the commercial cytosolic delivery agent PULSin, and the cytosolic delivery peptide Palm-1. Palm-1, a palmitylated peptide that is capable of both cellular uptake and rapid endosomal escape in multiple cell lines without concomitant toxicity, is shown to be the superior method for cytosolic delivery of QDs. Potential intracellular applications for this peptide are discussed.

Citation Download Citation

Kelly Boeneman Gemmill, Kelly Boeneman Gemmill, James B. Delehanty, James B. Delehanty, Michael H. Stewart, Michael H. Stewart, Kimihiro Susumu, Kimihiro Susumu, Juan B. Blanco-Canosa, Juan B. Blanco-Canosa, Philip E. Dawson, Philip E. Dawson, Alan Huston, Alan Huston, Igor Medintz, Igor Medintz, } "Further progress in cytosolic cellular delivery of quantum dots", Proc. SPIE 8232, Colloidal Nanocrystals for Biomedical Applications VII, 82320B (2 February 2012); doi: 10.1117/12.906801; https://doi.org/10.1117/12.906801

ACCESS THE FULL ARTICLE

PERSONAL SIGN IN
Full access may be available with your subscription

Email or Username Forgot your username?

Password Forgot your password?

Show

Remember Email/Username on this computer

Remember Password

No SPIE account? Create an account
or Institutional Sign In via Shibboleth

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $14.40

Non-members: $18.00 ADD TO CART

Show All Keywords

Keywords/Phrases

Search In:

Publication Years